Wendy’s Rejects Trian’s $7.35-a-Share Buyout, Adopts Poison Pill
Wendy's board rejected Trian Fund Management's $1.4 billion offer to take the burger chain private. How the poison pill works and what comes with it.
Wendy’s board has turned down a $1.4 billion offer from Nelson Peltz’s Trian Fund Management to take the burger chain private, the New York Post reported. The board also adopted a shareholder rights plan, often called a poison pill, which makes it much harder for one investor to gain control of the company without the board’s consent.
Trian, which already owns 16% of Wendy’s, had offered $7.35 per share. An independent committee of the board opposed the bid unanimously. Board Chairman Art Winkleblack said the committee concluded the offer “substantially undervalues” what Wendy’s can earn on its own over the long run.
How the Wendy’s poison pill works
The plan, adopted Thursday, is triggered if any person comes to own more than 15% of Wendy’s shares. Once that happens, other shareholders get the right to buy shares at a discount, according to the Post. Those cheap new shares shrink the stake of the investor who crossed the line, so building a controlling position through stock purchases becomes far more expensive.
The board framed the plan as protection against another takeover attempt. Trian made a hostile bid for Wendy’s in 2022 as well.
Trian’s argument for going private
Trian said Wendy’s is at a “critical juncture” and argued that a turnaround lasting several years would be easier to carry out away from the public market, the Post reported. When the offer became public last week, Wendy’s stock jumped 16%.
The Peltz family also has ties inside the company. Peltz’s son Bradley sits on the Wendy’s board and runs about 90 franchised restaurants in New York, New Jersey and Pennsylvania, according to the Wall Street Journal.
The board is sticking with its new CEO
Bob Wright became CEO in May after reviving sales at the Potbelly Sandwich Works chain. He has said Wendy’s will rebuild its menu from individual ingredients up through whole categories, and will rework how menu prices are set so customers see more value.
Wendy’s shares rose more than 2% after the company posted earnings on Thursday that beat expectations. Even so, the stock is down 24% this year and has lost more than 70% of its value over the past six years.
What it means for shareholders and franchisees
The rejection leaves Wendy’s shareholders with the board’s standalone turnaround plan in place of the $7.35 per share Trian proposed. The poison pill also caps how far Trian or any other investor can build a stake on the open market without setting off the discounted share sale.
The decision comes while the chain is getting smaller. Wendy’s closed 240 restaurants in 2024 and plans to close 358 in 2026. In September, one of its largest franchisees filed for bankruptcy protection. The company has more than 7,000 locations around the world.
Trian’s offer came after years of falling sales and franchise closures at the chain, the Post reported. Trian argued that the fix would be easier off the stock market, while the board chose to keep Wendy’s public under Wright’s menu and pricing plan.
Source: New York Post
